Jeffrey B. Kindler

Board Member · PRECIGEN, INC.

Rank #20,764 SEC EDGAR (United States) ↗ Files from United States

Details

Member of the boardPharmaceuticals & BiotechnologyPGENSEC CIK 0001174454

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$2.0M
1-day change
▼ 0.25%
Positions on file
3
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 3 currently disclosed positions would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$917.0K – $2.0M2026-09-04

Insider activity May 15, 2024 – Mar 13, 2026

Jeffrey B. Kindler is recorded in filings to the U.S. SEC via EDGAR as member of the board, and reported 14 transactions between May 15, 2024 and Mar 13, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$1.96M
4 sales on file priced rows only
All reported transactions
14
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 16 most recent rows are grouped into 15 lines by date, company and transaction type — open a line to see every lot with its own source link.

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. PRECIGEN, INC. PGEN S Open-market sale 185,000 shares $1.38M at $7.44 SEC filing ↗
  2. Praxis Precision Medicines, Inc. PRAX A Grant or awardnot a buy/sell decisionreported at zero 1,371 shares $0 at $0.00 SEC filing ↗
  3. PRECIGEN, INC. PGEN M Option exercise or conversionnot a buy/sell decisionreported at zero 71,839 shares $0 at $0.00 SEC filing ↗
  4. PRECIGEN, INC. PGEN A Grant or awardnot a buy/sell decision 19,658 shares $69.0K at $3.51 SEC filing ↗
  5. Praxis Precision Medicines, Inc. PRAX A Grant or award × 2not a buy/sell decisionreported at zero 1,166 shares $0
    The 2 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    688 $0.00reported at zero $0 SEC filing ↗
    478 $0.00reported at zero $0 SEC filing ↗
  6. PRECIGEN, INC. PGEN S Open-market sale 235,467 shares $854.7K at $3.63 SEC filing ↗
  7. PRECIGEN, INC. PGEN S Open-market sale 106,837 shares $361.1K at $3.38 SEC filing ↗
  8. PRECIGEN, INC. PGEN S Open-market sale 67,523 shares $243.1K at $3.60 SEC filing ↗
  9. PERRIGO Co plc PRGO F Shares withheld for taxesnot a buy/sell decision 4,754 shares $123.7K at $26.01 SEC filing ↗
  10. PERRIGO Co plc PRGO M Option exercise or conversionnot a buy/sell decision 9,904 shares $257.6K at $26.01 SEC filing ↗
  11. PRECIGEN, INC. PGEN M Option exercise or conversionnot a buy/sell decisionreported at zero 87,412 shares $0 at $0.00 SEC filing ↗
  12. PRECIGEN, INC. PGEN A Grant or awardnot a buy/sell decision 39,655 shares $69.0K at $1.74 SEC filing ↗
  13. PERRIGO Co plc PRGO S Open-market sale 17,598 shares $497.5K at $28.27 SEC filing ↗
  14. PERRIGO Co plc PRGO M Option exercise or conversionnot a buy/sell decision 8,764 shares $264.8K at $30.22 SEC filing ↗
  15. PERRIGO Co plc PRGO F Shares withheld for taxesnot a buy/sell decision 4,207 shares $127.1K at $30.22 SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
PRECIGEN, INC. PGEN Common Stock 202,100 $7.10 $1.4M 4 EDGAR ↗
Praxis Precision Medicines, Inc. PRAX Common Stock 1,166 $351.81 $410.2K 4 EDGAR ↗
PERRIGO Co plc PRGO Ordinary Shares 10,559 $14.92 $157.5K 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Jeffrey B. Kindler reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.